Russell LaMontagne
Founder at Boston Immune Technologies & Therapeutics, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Bruce A. Beutel | M | 60 |
Boston Immune Technologies & Therapeutics, Inc.
 Boston Immune Technologies & Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Boston Immune Technologies & Therapeutics, Inc. is a company based in MA that develops a novel class of antagonist antibodies targeting the TNF superfamily receptors for applications in oncology, inflammation, autoimmunity, and infectious disease. The company is based in Winchester, MA. The company is also developing additional TNF superfamily antibodies including CD40 antagonists for inflammation and CD30 antagonists for oncology. The company was founded by Russell LaMontagne and he has been the CEO since incorporation. | - |
| Denise Faustman | F | - |
Boston Immune Technologies & Therapeutics, Inc.
Boston Immune Technologies & Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Boston Immune Technologies & Therapeutics, Inc. is a company based in MA that develops a novel class of antagonist antibodies targeting the TNF superfamily receptors for applications in oncology, inflammation, autoimmunity, and infectious disease. The company is based in Winchester, MA. The company is also developing additional TNF superfamily antibodies including CD40 antagonists for inflammation and CD30 antagonists for oncology. The company was founded by Russell LaMontagne and he has been the CEO since incorporation. | - |
Connections Chart
Multi-company connection
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 2 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Russell LaMontagne
- Personal Network
